Amelioration of established collagen induced arthritis by systemic IL-10 gene delivery (Q45868500)

17 December 2017

title

Amelioration of established collagen induced arthritis by systemic IL-10 gene delivery (English)

1 reference

17 December 2017

author name string

Fellowes R

1

1 reference

17 December 2017

Etheridge CJ

2

1 reference

17 December 2017

Coade S

3

1 reference

17 December 2017

Cooper RG

4

1 reference

17 December 2017

Stewart L

5

1 reference

17 December 2017

Miller AD

6

1 reference

17 December 2017

Woo P

7

1 reference

17 December 2017

publication date

1 June 2000

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

7

1 reference

17 December 2017

issue

11

1 reference

17 December 2017

page(s)

967-977

1 reference

17 December 2017

Collagen arthritis--what can it teach us?

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301165

Tumour necrosis factor in synovial exudates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301165

Enhanced production of interleukin-6 in mice with type II collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301165

Immunoregulatory role of interleukin 10 in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301165

Detection of transforming growth factor-beta in rheumatoid arthritis synovial tissue: lack of effect on spontaneous cytokine production in joint cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301165

Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301165

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301165

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301165

Gene therapy of rheumatoid arthritis via cytokine regulation: future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301165

Mac-1: a macrophage differentiation antigen identified by monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301165

Gene therapy in the United States: a five-year status report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301165

Immunostimulatory cytokines in somatic cells and gene therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301165

Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301165

Suppression of collagen-induced arthritis through adenovirus-mediated transfer of a modified tumor necrosis factor alpha receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301165

Immune modulation by IL-10 gene transfer via viral vector and plasmid DNA: implication for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301165

Plasmid DNA encoding transforming growth factor-beta1 suppresses chronic disease in a streptococcal cell wall-induced arthritis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301165

Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301165

Specific accumulation of cholesterol-rich liposomes in the inflammatory tissue of rats with adjuvant arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301165

Human tumor necrosis factor receptor (p55) and interleukin 10 gene transfer in the mouse reduces mortality to lethal endotoxemia and also attenuates local inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301165

Endothelial cell transfection with cationic liposomes and herpes simplex-thymidine kinase mediated killing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301165

Cationic liposome-mediated intravenous gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301165

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301165

Regulation of contact hypersensitivity by interleukin 10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301165

Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301165

Anti-inflammatory activity of cationic lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301165

Transient human gene therapy: a novel cytokine regulatory strategy for experimental pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301165

Bacterial lipopolysaccharide copurifies with plasmid DNA: implications for animal models and human gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301165

Structural studies on cartilage collagen employing limited cleavage and solubilization with pepsin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301165

Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301165

Interleukin-10 inhibition of the progression of established collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301165

Long-term amelioration of rat adjuvant arthritis following systemic elimination of macrophages by clodronate-containing liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301165

7 January 2021

Augmented interleukin-1 production and HLA-DR expression in the synovium of rheumatoid arthritis patients. Possible involvement in joint destruction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301165

7 January 2021

Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301165

7 January 2021

Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301165

7 January 2021

Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNF alpha, anti-IL-1 alpha/beta, and IL-1Ra

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301165

7 January 2021

Interleukin-10 suppresses the development of collagen type II-induced arthritis and ameliorates sustained arthritis in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301165

7 January 2021

Effect of IL-10 on collagen-induced arthritis in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301165

7 January 2021

Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301165

7 January 2021

Suppression of adjuvant-induced arthritis by liposomally conjugated methotrexate in the rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301165

7 January 2021

Attenuation of collagen-induced arthritis in mice by treatment with vector cells engineered to secrete interleukin-13

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301165

7 January 2021

Neo-mannosylated liposomes: synthesis and interaction with mouse Kupffer cells and resident peritoneal macrophages

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301165

7 January 2021

Preparation and characterisation of liposomes containing mannosylated phospholipids capable of targetting drugs to macrophages

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301165

7 January 2021

Gene Transfer In Vivo with DNA–Liposome Complexes: Safety and Acute Toxicity in Mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301165

7 January 2021

Direct gene delivery to synovium. An evaluation of potential vectors in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301165

7 January 2021

Subcutaneous administration of liposomes: a comparison with the intravenous and intraperitoneal routes of injection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301165

7 January 2021

Collagen-induced arthritis in DBA/1 mice: cytokine gene activation following immunization with type II collagen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301165

7 January 2021

Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301165

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301165

1 reference

17 December 2017

Dimensions Publication ID

1027945452

0 references

1 reference

17 December 2017